Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy

NCT ID: NCT00378547

Last Updated: 2010-01-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

147 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients scheduled for a tonsillectomy need postoperative pain treatment. Some of the most widely used postoperative analgetics (NSAIDs) sometimes cause rebleeding in the postoperative period, and another often used analgetic, morphine, causes nausea and vomiting. The researchers therefore will investigate new combinations of postoperative analgesics in hopes of improving pain and the need for opioids during the postoperative period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will investigate the effect of paracetamol versus paracetamol combined with pregabalin versus paracetamol combined with pregabalin and dexamethasone on pain and morphine requirements in the first 24 hours postoperatively. Outcomes include amount of morphine and ketobemidone used, and pain measured on a VAS scale. Side-effects, e.g., PONV, dizziness and sedation are also measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Paracetamol

Oral paracetamol 1 g + placebo + placebo

Group Type PLACEBO_COMPARATOR

paracetamol + placebo + placebo

Intervention Type DRUG

Comparing the analgesic effect of combinations of paracetamol + placebo + placebo

Paracetamol + Pregabalin

Oral paracetamol 1g + oral pregabalin 300 mg + placebo

Group Type EXPERIMENTAL

paracetamol + pregabalin + placebo

Intervention Type DRUG

Comparing the analgesic effect of combinations of paracetamol + pregabalin 300 mg + placebo

Paracetamol + pregabalin + dexamethasone

Oral paracetamol 1g + oral pregabalin 300 mg + IV dexamethasone 8 mg

Group Type EXPERIMENTAL

paracetamol + pregabalin + dexamethasone

Intervention Type DRUG

Comparing the analgesic effect of combinations of paracetamol + pregabalin 300 mg + dexamethasone 8 mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

paracetamol + placebo + placebo

Comparing the analgesic effect of combinations of paracetamol + placebo + placebo

Intervention Type DRUG

paracetamol + pregabalin + placebo

Comparing the analgesic effect of combinations of paracetamol + pregabalin 300 mg + placebo

Intervention Type DRUG

paracetamol + pregabalin + dexamethasone

Comparing the analgesic effect of combinations of paracetamol + pregabalin 300 mg + dexamethasone 8 mg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Acetaminophen Acetaminophen Pregabalin Acetaminophen Pregabalin Dexamethasone

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for benign tonsillectomy
* Between the ages of 18 and 50 years old
* ASA 1-2 and a surgical technique without the need for local anaesthetics or electrical scissors

Exclusion Criteria

* Malignancy
* Patients who are unable to cooperate
* Does not speak Danish
* Has allergy for drugs used in the trial
* Has abused drugs and/or medicine
* Epilepsy
* Diabetes treated with medicine
* Treatment with systemic steroids 4 weeks prior to the operation
* Daily use of antacids
* Daily use of analgesics
* Use of antidepressives
* Known kidney disease
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Glostrup University Hospital, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Section of Acute Pain Management and Palliative Care

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ole Mathiesen, MD

Role: STUDY_CHAIR

Department of Anaesthesiology, Copenhagen University Hospital in Glostrup, 2600 Glostrup, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Day Case Surgery at Glostrup University Hospital

Glostrup Municipality, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SM4-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Opioid-Free Anesthetic for Tonsillectomy
NCT04528173 TERMINATED PHASE4